July 2018
Volume 59, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2018
Feasibility of Intraocular Forward-Imaging B-scan Optical Coherence Tomography Probe to Guide Subretinal Injections
Author Affiliations & Notes
  • TOMAS A Moreno
    Vanderbilt Eye Institute, Vanderbilt University Medical Center, Nashville, Tennessee, United States
  • Jin H Shen
    Vanderbilt Eye Institute, Vanderbilt University Medical Center, Nashville, Tennessee, United States
  • Yuankai Tao
    Biomedical Engineering , Vanderbilt University, Nashville, Tennessee, United States
  • Karen M Joos
    Vanderbilt Eye Institute, Vanderbilt University Medical Center, Nashville, Tennessee, United States
    Biomedical Engineering , Vanderbilt University, Nashville, Tennessee, United States
  • Footnotes
    Commercial Relationships   TOMAS Moreno, None; Jin Shen, Vanderbilt University (P); Yuankai Tao, Leica Microsystems (R), Vanderbilt University (P); Karen Joos, Vanderbilt University (P)
  • Footnotes
    Support  Sousan and Black Research Funds, NIH P30EY008126 to Vanderbilt Vision Research Center, Unrestricted Departmental Grant from Research to Prevent Blindness, Inc., N.Y. to the Vanderbilt Eye Institute
Investigative Ophthalmology & Visual Science July 2018, Vol.59, 286. doi:https://doi.org/
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      TOMAS A Moreno, Jin H Shen, Yuankai Tao, Karen M Joos; Feasibility of Intraocular Forward-Imaging B-scan Optical Coherence Tomography Probe to Guide Subretinal Injections. Invest. Ophthalmol. Vis. Sci. 2018;59(9):286. doi: https://doi.org/.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Subretinal injections are increasing important for gene therapy but require micrometer accuracy. Therefore, we investigated the feasibility of a novel optical coherence tomography (OCT) probe continuously imaging a microneedle tip to perform subretinal injections.

Methods : A 36-gauge coplanar needle attached to a 25-gauge B-scan OCT (870 nm) probe was introduced through a trocar into the vitreous cavity of fresh ex-vivo porcine eyes. The proximal end was connected to a microliter pump, which released 20 µL (200 µL/min) of green-dyed balanced salt solution. Subretinal injections were performed by viewing a split-screen heads-up display (TrueVision Systems Inc., Santa Barbara, CA) with the simultaneous en face 3D surgical microscope image on the left and the real-time unprocessed continuous B-scan OCT image from the probe on the right. Observations were recorded.

Results : The microneedle OCT probe successfully tracked the needle tip through the vitreous and retinal layers in real time to the desired subretinal location without entering the retinal pigment epithelium (RPE). It simultaneously imaged the needle tip and lifting of the retina from the RPE during injection. No focusing or tracking computer algorithms were required to maintain the needle tip image. The heads-up display permitted simultaneous real-time visualization of the microscope en face and B-scan OCT images to provide wide-field and localized inputs. The microneedle OCT probe also provided unique observations that were not readily seen en face. These included: 1) OCT visualization of the exact needle tip position at all times, 2) clear retinal imaging with subretinal injection performance despite corneal or lenticular media opacities, 3) RPE disturbance at the injection site, 4) imaging of the far peripheral retina, and 5) retinal edema formation during injection. Fluid reflux through the retinotomy was observed en face.

Conclusions : The novel microneedle OCT probe demonstrated capacity for subretinal injection delivery. The B-scan OCT device continuously imaged the needle tip traveling through the eye. It then visualized formation of the retinal bleb during injection.

This is an abstract that was submitted for the 2018 ARVO Annual Meeting, held in Honolulu, Hawaii, April 29 - May 3, 2018.

 

The microneedle OCT probe is performing a subretinal injection with the simultaneous en face microscope image and the B-scan OCT image displayed. (Arrows: needle tip, yellow; retina, red; subretinal fluid, green; RPE, blue; OCT probe, white).

The microneedle OCT probe is performing a subretinal injection with the simultaneous en face microscope image and the B-scan OCT image displayed. (Arrows: needle tip, yellow; retina, red; subretinal fluid, green; RPE, blue; OCT probe, white).

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×